The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...

"Dancing with the Stars" alum Cheryl Burke responds to appearance critiques, highlighting her journey of healing, growth and ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...

Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but without diabetes, highlighting its superior effectiveness and cardiometabolic ...

Unions blame ‘greed’ by healthcare providers, state officials say pricey weight-loss meds and increasing demand for care are ...

At Little Fino, the newly opened bar and cafe at the William Vale in Williamsburg, compact choices include the “Mole Martinez ...

As weight loss medications like Ozempic continue to gain popular, experts and patients are noticing varying effects of the ...

Dozens of Ozempic and Wegovy users have reported suffering from eye disorders they claim are associated with the drugs, ...